MRK vs ELV
By Alex · Tickerpine
Merck & Co., Inc. vs Elevance Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | ELV |
|---|---|---|
| Price | $128.66 | $395.18 |
| Market cap | $317.77B | $85.82B |
| P/E ratio | 36.2 | 16.8 |
| ROE | 18.94% | 12.09% |
| Profit margin | 13.59% | 2.62% |
| Revenue growth | 4.90% | 2.60% |
| Dividend yield | 2.64% | 1.74% |
| Beta | 0.22 | 0.68 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs ELV in plain English
- MRK is the bigger company — about 3.7× the market cap of ELV.
- ELV is cheaper on earnings (P/E 16.8 vs 36.2).
- MRK earns a higher return on equity (19% vs 12%).
- MRK is growing revenue faster (5% vs 3%).
- MRK has the higher dividend yield (2.64% vs 1.74%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
ELV return calculator
See what $1,000 in Elevance Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.